<DOC>
	<DOC>NCT00140712</DOC>
	<brief_summary>This is a two-period dose rising study of Ropinirole Immediate Release in adolescent patients with restless legs syndrome (RLS) in order to determine the starting dose for the ropinirole titration regimen for this age group. Patients will receive two single doses unless poor tolerability is observed following the first dose.</brief_summary>
	<brief_title>Ropinirole Tablets In Young Patients With Restless Legs Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Ropinirole</mesh_term>
	<criteria>Adolescent subjects diagnosed with probable or definite Restless Leg Syndrome (RLS). Subjects who require RLS treatment during the daytime, suffer from other primary sleep disorders or are taking medication known to induce drowsiness, affect RLS or sleep, or to induce or treat alertness, including methylphenidate.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Adolescent</keyword>
	<keyword>RLS</keyword>
	<keyword>Periodic Limb Movements of Sleep</keyword>
	<keyword>PLMS</keyword>
	<keyword>Ropinirole</keyword>
</DOC>